Dwight Moxie Revance Therapeutics, Inc. (RVNC) insider trading activity

Dwight Moxie is CLO & GC of Revance Therapeutics, Inc.. Currently has a direct ownership of 137,815 shares of RVNC, which is worth approximately $354,184. The most recent transaction as insider was on Mar 18, 2024, when has been sold 8,125 shares (Common Stock) at a price of $5.04 per share, resulting in proceeds of $40,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 138K

0% 3M change

2.8% 12M change

Total Value Held $354,184

Dwight Moxie Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2024	SELL Open market or private sale	$40,950 $5.04 p/Share	8,125 Reduced 5.57%	137,815 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$17,325 $5.3 p/Share	3,269 Reduced 2.19%	145,940 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	15,143 Added 9.21%	149,209 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	90,000 Added 40.17%	134,066 Common Stock
Sep 06 2023	SELL Open market or private sale	$187,660 $17.06 p/Share	11,000 Reduced 19.98%	44,066 Common Stock
Sep 05 2023	SELL Open market or private sale	$424,821 $17.81 p/Share	23,853 Reduced 30.22%	55,066 Common Stock
Aug 11 2023	SELL Payment of exercise price or tax liability	$181,384 $18.91 p/Share	9,592 Reduced 10.84%	78,919 Common Stock
Aug 11 2023	BUY Grant, award, or other acquisition	-	19,346 Added 17.94%	88,511 Common Stock
May 15 2023	SELL Open market or private sale	$739,404 $34.55 p/Share	21,401 Reduced 23.63%	69,165 Common Stock
Mar 15 2023	SELL Payment of exercise price or tax liability	$224,664 $30.65 p/Share	7,330 Reduced 13.2%	48,217 Common Stock
Mar 09 2023	SELL Open market or private sale	$584,288 $31.59 p/Share	18,496 Reduced 24.98%	55,547 Common Stock
Sep 22 2022	BUY Grant, award, or other acquisition	-	42,349 Added 36.38%	74,043 Common Stock
Sep 14 2022	SELL Open market or private sale	$297,770 $27.07 p/Share	11,000 Reduced 25.76%	31,694 Common Stock
Mar 15 2022	SELL Payment of exercise price or tax liability	$80,687 $15.79 p/Share	5,110 Reduced 10.69%	42,694 Common Stock
Feb 02 2022	BUY Grant, award, or other acquisition	-	42,349 Added 31.86%	90,566 Common Stock
Sep 27 2021	SELL Open market or private sale	$50,250 $30.0 p/Share	1,675 Reduced 3.39%	47,804 Common Stock
Mar 15 2021	SELL Payment of exercise price or tax liability	$79,890 $27.73 p/Share	2,881 Reduced 5.5%	49,479 Common Stock
Feb 02 2021	BUY Grant, award, or other acquisition	-	19,346 Added 26.98%	52,360 Common Stock
Sep 30 2020	SELL Payment of exercise price or tax liability	$106,493 $25.14 p/Share	4,236 Reduced 11.37%	33,014 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	-	12,250 Added 24.75%	37,250 Common Stock

Dwight Moxie

CLO & GC

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Value

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC

Account